Kontrowersje wokół pewnego normotymiku. Historia litu

• Authors: Kabzińska Karolina , Czajeczny Dominik

Title variants

EN

The controversy around a mood stabilizer. The history of lithium

• Languages of publication: PL

Abstracts

PL

Stygmat osoby z zaburzeniem psychicznym funkcjonuje we wszystkich społeczeństwach od bardzo dawna. Wczesne próby leczenia owych przypadłości różnymi specyfikami nie skutkowały poprawą funkcjonowania chorych. Dopiero rozwój psychofarmakoterapii pozwolił na stosowanie konkretnych substancji w poszczególnych zaburzeniach. Używane od połowy XX wieku związki litu pozostają wciąż standardem, do którego porównywane są wszystkie nowsze leki normotymiczne. Powszechnie stosowane są w chorobie afektywnej dwubiegunowej, działając zarówno na stany maniakalne jak i depresyjne. Wprowadzenie tego leku na rynek farmaceutyczny budziło wiele kontrowersji w środowisku naukowym. Jego wysoka skuteczność w obszarze prewencji samobójstwom oraz w zakresie profilaktyki nawrotów potwierdza efektywność leku, natomiast nie wyklucza występowania skutków ubocznych odstraszających pacjentów.

EN

: This is a review article on the history of psychopharmacotherapy. For a very long time, persons with mental disorders have been stigmatizing in all societies. Early attempts to treat mental illness by different medications were not effective. Only the development of psychopharmacology allowed to use specific substances against particular disorders. Since the mid-20th century lithium compounds have been the psychopharmacological standard to which all new normothymic drugs are compared. Lithium compounds are used to treat bipolar affective disorder, because they are acting on both maniacal and depressive states. Placing the lithium compounds on the pharmaceutical market was controversial for scholars in the past. On the one hand, they are effective in preventing suicide and recurrences of the disease, on the other, adverse effects may deter patients.

Keywords

PL

historia psychofarmakologii,; lit,; leki normotymiczne

EN

history of psychopharmacology,; lithium,; normothymic drugs

• Publisher: Uniwersytet Medyczny w Poznaniu
• Journal: Acta Medicorum Polonorum
• Year: 2018
• Volume: 8
• Issue: 2
• Pages: 36-51
• Document type: review article

Dates

printed

2019-01-15

Contributors

author

Kabzińska Karolina

• Uniwersytet Medyczny w Poznaniu

author

Czajeczny Dominik

• Uniwersytet Medyczny w Poznaniu

References

• Baastrup P.C., Schou M., Lithium as a Prophylactic Agents. Its Effect against Recurrent Depressions and Manic-Depressive Psychosis, "Archives of General Psychiatry", 1967,16(2), s.162–172.
• Baldessarini R.J., Tondo L, Davis P. et al., Decreased Risk of Suicides and Attempts during Long-Term Lithium Treatment: A Meta-Analytic Review, "Bipolar Disorder", 2006, 8: s. 625–639.
• Bech P., The Full Story of Lithium. A Tribute to Mogens Schou (1918-2005), "Psychotherapy and Psychosomatics", 2006, 75(5), s. 265–269.
• Birch N.J., Inorganic Pharmacology of Lithium, "Chemical Reviews", 1999, 99(9), s. 2659–2682.
• Blackwell B., Shepherd M., Prophylactic Lithium: Another Therapeutic Myth? An Examination of the Evidence to Date, "Lancet" 1968,1(7549), s. 968–971.
• Bunney W.E., Goodwin K., Davis J. M., Fawcett J. A., A Behavioral-Biochemical Study of Lithium Treatment, "The American Journal of Psychiatry", 1968 125(4), s. 499–512.
• Cade J., Lithium Salts in the Treatment of Psychotic Excitement, "The Medical Journal of Australia" 1949, 2(10), s. 349–351.
• Calabrese J.R., Bowden C. L., Sachs G. et al., A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients with Bipolar I Disorder, "The Journal of Clinical Psychiatry", 2003, 64(9), s. 1013–1024.
• Cipriani A., Pretty H., Hawton K., Geddes J. R., Reviews and Overviews Lithium in the Prevention of Suicidal Behavior and All- Cause Mortality in Patients with Mood Disorders: A Systematic Review of Randomized Trials, "Am J Psychiatry", 2005, 152(10), s. 1805–1819.
• Cowen P.J., Czy psychofarmakologia ma przyszłość? "The British Journal of Psychiatry", 2001, 198, s. 333–335.
• Cuijpers P., Sijbrandij M., Koole S. L. et al., The Efficacy of Psychotherapy and Pharmacotherapy in Treating Depressive and Anxiety Disorders: A Meta-Analysis of Direct Comparisons, "World Psychiatry", 2013, 12(2), s. 137–148, doi: 10.1002/wps.20038.
• Dembińska-Krajewska D., Kliwicki S., Chłopocka-Woźniak M, Rybakowski J. K., Skuteczność profilaktycznego stosowania litu w chorobie afektywnej dwubiegunowej a cechy schizotypii, "Farmakoterpia w Psychiatrii i Neurologii", 2012, 3–4, s. 153–158.
• Dunn N., Holmes C., Mullee M., Does Lithium Therapy Protect against the Onset of Dementia? "Alzheimer Disease and Associated Disorders", 2005, 19(1), s. 20–22.
• Forlenza O.V. et al., Does Lithium Prevent Alzheimer’s Disease? "Drugs & Aging", 2012, 29(5), s. 335–342, doi: 10.2165/11599180-000000000-00000.
• Gelenberg A.J., Jefferson J.W., Lithium Tremor, "J Clin Psychiatry", 1995, 56(7), s. 283–287.
• Gelfo F., Cutuli D., Nobili A., et al., Chronic Lithium Treatment in a Rat Model of Basal Forebrain Cholinergic Depletion: Effects on Memory Impairment and Neurodegeneration, "J Alzheimers Dis.", 2017, 56(4), s. 1505–1518, doi: 10.3233/JAD-160892.
• Gershon S., Yuwiler A., Lithium Ion: A Specific Psychopharmacological Approach to the Treatment of Mania, "Journal of Neuropsychiatry", 1960, 1, s. 229–241.
• Gitlin M., Lithium Side Effects and Toxicity: Prevalence and Management Strategies, "International Journal of Bipolar Disorders", 2016, 4(27).
• Godwin F.K., Jamison K.R., Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd Edition, 2007.
• Goodwin F.K., Murphy D. L., Bunney W. E. Jr, Lithium-Carbonate Treatment in Depression and Mania. A Longitudinal Double-Blind Study, "Archives of General Psychiatry", 1969, 21(4), s. 486–496.
• Grof P., Duffy A., Alda M., Hajek T., Lithium Response across Generations, "Acta Psychiatrica Scandinavica", 2009, 120(5), s. 378–385, doi: 10.1111/j.1600-0447.2009.01454.x.
• Grover S. et al., Sexual Dysfunction in Clinically Stable Patients with Bipolar Disorder Receiving Lithium, "J Clin Psychopharmacol.", 2014, 34(4), s. 475–482, doi: 10.1097/JCP.0000000000000131.
• Ivanets N.N. et al., [An increase in the efficacy of psychopharmacotherapy of late-onset depressions: combination and substitution of antidepressants], "Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova", 2016, 116(5), s. 43–51, doi: 10.17116/jnevro20161165143-51.
• Kabacs N., Memon A., Obinwa T., Stochl J., Perez J., Lithium in drinking water and suicide rates across the East of England, "Br J Psychiatry J Ment Sci.", 2011,198(5), s. 406–7, doi: 10.1192/bjp.bp.110.088617.
• Kessing L., Andersen P.K., Laier G., Predictors of Excellent Response to Lithium: Results from a Nationwide Register-Based Study Predictors of Excellent Response to Lithium : Results from a Nationwide Register-Based Study, "International Clinical Psychopharmacology", 2011, 26(6), s. 323–328, doi: 10.1097/YIC.0b013e32834a5cd0.
• Kolch M., Plener P. L., Pharmacotherapy in Psychiatric Disorders of Children: Current Evidence and Trends, "Pharmacopsychiatry", 2016, 49(6), s. 219–225, doi: 10.1055/s-0042-117644.
• Kostowski W., Rozwój leków przeciwpsychotycznych: atypowe neuroleptyki, "Postępy Psychiatrii i Neurologii", 1997, 6, s. 85–99.
• Koszewska I., Dziurawiec zwyczajny w leczeniu depresji, "Farmakoterpia w Psychiatrii i Neurologii", 2003, 1, s. 45–54.
• Początki leczenia chlorpromazyną w polskiej psychiatrii, "Psychiatria i Psychoterapia", 2013, 9(3), s. 3–23.
• López-Jaramillo C., Lopera-Vásquez J., Gallo A. et al., Effects of Recurrence on the Cognitive Performance of Patients with Bipolar I Disorder: Implications for Relapse Prevention and Treatment Adherence, "Bipolar Disorder", 2010, 12(5), s. 557–567, doi: 10.1111/j.1399-5618.2010.00835.x.
• Makara-Studzińska M., Koślak A., Morylowska-Topolska J., Urbańska A., Lithium Therapy – the Effectiveness of the Medicine, Side Symptoms, Complications and Their Influence on the Quality of the Life in Affective Diseases, "J. Elementol.", 2010, 15(2), s. 393–403.
• Malhi G.S., Tanious M., Das P., Berk M., The Science and Practice of Lithium Therapy, "The Australian and New Zealand Journal of Psychiatry", 2012, 46(3), s. 192–211, doi: 10.1177/0004867412437346.
• Nivoli A., Murru A., Vieta E., Lithium: Still a Cornerstone in the Long-Term Treatment in Bipolar Disorder? "Neuropsychobiology", 2010, 62(1), s. 27–35, doi: 10.1159/000314307.
• Nordenström J., Elvius M,, Bågedahl-Strindlund M., Zhao B., Törring O., Biochemical Hyperparathyroidism and Bone Mineral Status in Patients Treated Long-Term with Lithium, "Metabolism", 1994, 43(12), s. 1563–1567.
• Nunes M.A., Viel T.A., Buck H.S., Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer’s disease, "Curr Alzheimer Res.", 2013,10(1), s.104–7.
• Quiroz J.A., Machado-Vieira R., Zarate C.A., Novel Insights into Lithium’s Mechanism of Action : Neurotrophic and Neuroprotective Effects, "Neuropsychobiology", 2010, 62, s. 50–60, doi: 10.1159/000314310.
• Richer S., Stiles W., Statkute L. et al., Double-masked, placebo controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial), "Optom St Louis Mo.", 2004,75(4), s. 216–30.
• Rybakowski J. K., Suwalska A., Excellent Lithium Responders Have Normal Cognitive Functions and Plasma BDNF Levels, "International Journal of Neuropsychopharmacology", 2010, 13, s. 617–622, doi: 10.1017/S1461145710000404.
• Rybakowski J. K., Lithium in Neuropsychiatry: A 2010 Update, "The World Journal of Biological Psychiatry", 2011, 12(5), s. 340–348, doi: 10.3109/15622975.2011.559274.
• Schou M., Forty Years of Lithium Treatment, "Archives of General Psychiatry", 1997, 54(1), s. 9–13; discussion 14-15.
• Schou M., Juel-Nielsen N., Strömgren E., Voldby H., The Treatment of Manic Psychoses by the Administration of Lithium Salts, "J Neurol Neurosurg Psychiatry", 1954, 17(4), s. 250–260.
• Schou M., Lithium Treatment of Manic Depressive Illness: A Practical Guide. Basel 1992.
• Schrauzer G.N., Shrestha K.P., Flores-Arce M.F., Lithium in scalp hair of adults, students, and violent criminals, "Biol Trace Elem Res.", 1992, 34(2), s. 161–76.
• Seiler H. G., Handbook of Toxicity of Inorganic Compounds. CRC Press, 1978.
• Senturk V., Goker C., Bilgic A. et al., Impaired Verbal Memory and Otherwise Spared Cognition in Remitted Bipolar Patients on Monotherapy with Lithium or Valproate, "Bipolar Disord", 2007, 9(1), s. 136–144.
• Shorter E., Before Prozac. The Troubled History of Mood Disorders in Psychiatry. Oxford 2009.
• Shorter E., The History of Lithium Therapy, "Bipolar Disorders"11(Suppl 2), 2009, s. 4–9.
• Stafińska M., Historia leków psychotropowych, "Postępy Farmacji", http://openin.pl/index.php?option=com_content&view=article&id=156:historia-lekow-psychotropowych&catid=35&Itemid=213.
• Strzelecki D., Stabilizatory nastroju w leczeniu choroby afektywnej dwubiegunowej, "Psychoterapia i Uzależnienia", 2017, (2), s. 1–7.
• Sulich A., Odwzorowanie wiedzy w nazwach pierwiastków chemicznych, "Studia Semiotyczne", 2010, 27: 93–133.
• Szklarska D., Rzymski P., Is Lithium a Micronutrient? From Biological Activity and Epidemiological Observation to Food Fortification, "Biol Trace Elem Res.", 2018, 31, doi: 10.1007/s12011-018-1455-2.
• Terao, T. Is Lithium Potentially a Trace Element?, "World J Psychiatry", 2015, 22;5(1), s. 1–3, doi: 10.5498/wjp.v5.i1.1.
• Vikstrom H., Davidsson S., Hook M., Lithium Availability and Future Production Outlooks, "Applied Energy", 2013, 110, s. 252–266.
• Weeks M.E., Discovery of the Elements, "Journal Of Chemical Education", 1956.
• Wojciak R.W., Mojs E., Stanislawska-Kubiak M., The Occurrence of Iron-Deficiency Anemia in Children with Type 1 Diabetes. "Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research", 2014, 62(6): 865–867, doi: 10.1097/JIM.0000000000000098.
• Wojciak R.W., Effect of Short-Term Food Restriction on Iron Metabolism, Relative Well-Being and Depression Symptoms in Healthy Women, "Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity", 2014, 19(3), s. 321–327, doi: 10.1007/s40519-013-0091-2.
• Yazlovitskaya E. M., Edwards E., Thotala D., et al., Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation, "Cancer Res", 2006, 66(23), s. 11179–11186.
• Zamani A., Omrani G.R., Nasab M.M., Lithium’s Effect on Bone Mineral Density, "Bone", 2009, 44(2), s. 331–334, doi: 10.1016/j.bone.2008.10.001.
• Zarse K., Terao T., Tian J. et al., Low-dose lithium uptake promotes longevity in humans and metazoans, “Eur J Nutr.”, 2011,50(5):387–9, doi: 10.1007/s00394-011-0171-x.